Else Nutrition Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Else Nutrition Holdings generated cash of -$18,311,000, which is more than the previous year. Cash used in financing activities reached the amount of $7,443,000 last year. Net change in cash is therefore -$11,633,000.
Cash Flow
| 2016 | -66.74K | -33.02K | 30.75K |
|---|---|---|---|
| 2018 | -12.48K | 0 | 563.31K |
| 2019 | -3.06M | -614K | 6.61M |
| 2020 | -9.58M | -3.93M | 32.44M |
| 2021 | -15.76M | 1.14M | 16.85M |
| 2022 | -20.91M | 170K | 11.68M |
| 2023 | -18.31M | -1.12M | 7.44M |
BABY.TO Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.56M | 23.04M | 21.53M | 2.90M | 10K | 13.94K | 74.00K |
Operating activities | |||||||
Net income | -15.60M | -17.61M | -1.61M | -24.10M | -5.37M | -107.84K | -54.12K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 379K | 496K | 384K | 193K | 74K | 0 | 0 |
Stock-based compensation expense | 353K | 1.09M | 2.20M | 1.02M | 253K | 0 | 0 |
| Deferred income tax benefit | 353K | 1.09M | 2.20M | 1.02M | 253K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 58K | -774K | -303K | 160K | -506K | -191 | 15.94K |
Inventories | -1.53M | -1.02M | -2.08M | -2.22M | -63K | 0 | 0 |
Accounts payable | -411K | 244K | 729K | 902K | 169K | 53.76K | 0 |
Cash generated by operating activities | -18.31M | -20.91M | -15.76M | -9.58M | -3.06M | -12.48K | -66.74K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | -3.17M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -160K | -287K | -230K | -508K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | -452K | 0 | -33.02K |
Cash generated by investing activities | -1.12M | 170K | 1.14M | -3.93M | -614K | 0 | -33.02K |
Financing activities | |||||||
Common Stock Issued | 4.39M | 6.74M | 16.01M | 32.99M | 6.63M | 563.31K | 30.75K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 3.00M | 4.94M | -259K | -117K | -38K | 0 | 0 |
Cash used in financing activities | 7.44M | 11.68M | 16.85M | 32.44M | 6.61M | 563.31K | 30.75K |
Net Change In Cash | -11.63M | -8.48M | 1.50M | 18.62M | 2.89M | 550.83K | -69.01K |
Cash at end of period | 2.93M | 14.56M | 23.04M | 21.53M | 2.90M | 564.77K | 4.99K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |